The Hindu Business Line

Patent wins may keep Suven in good health


Suven Life Sciences on Wednesday informed the bourses of the grant of one product patent each from Israel, Japan, New Zealand and Sri Lanka. The patent is for new chemical entities indicated for the treatment of disorders associated with neurodegen­erative diseases such as Alzheimer’s disease, attention deficient hyperactiv­ity disorder (ADHD), Huntington’s disease, pain, Parkinson’s disease, and Schizophre­nia, among others. Shareholde­rs will closely monitor further developmen­ts.

Newspapers in English

Newspapers from India